These sections help you find topics. They are not a medical stage assignment. Choose any topic that matches your questions.
Answer a random selection of 10 questions from across the topics. Untimed, with teaching notes after every question. Your answers are saved in My Takeaways.
Start 10 questions40 topics shown
Where the prostate sits, how it makes semen, how testosterone supports cancer growth, why early cancer causes no symptoms, how enlargement differs from cancer, what PSA measures, why PSA alone cannot diagnose cancer, and what rectal examinations assess.
New questions are being added (Fall/Winter 2026).
How biopsy confirms cancer in tissue, biopsy route and infection risk, interpreting positive sample counts, what adenocarcinoma means, how Gleason scores and Grade Groups are calculated, why pattern order matters, and both sides of your family cancer history.
New questions are being added (Fall/Winter 2026).
How MRI guides targeted tissue sampling, how PI-RADS measures cancer suspicion, the purposes of CT and bone scans, what PSMA PET looks for, and why scans can miss microscopic disease.
New questions are being added (Fall/Winter 2026).
The difference between cancer grade and stage, node involvement versus distant spread, nearby growth without distant spread, what distant metastasis means, factors defining risk groups, how risk changes treatment choices, and why survival statistics are not forecasts.
New questions are being added (Fall/Winter 2026).
Curative intent without guaranteed cure, how other illnesses affect treatment benefit, balancing cancer control with function, how soon to decide, the purpose of second opinions, understanding before consenting, voluntary participation in clinical trials, comparing treatments using personal priorities, complementary care versus replacing treatment, and checking cancer information for reliability.
New questions are being added (Fall/Winter 2026).
Comparing surgical and radiation opinions, why specialists review care together, your specialist nurse's role, prioritizing questions before appointments, how supporters help with recall, explaining your plan back, respectful care without identity assumptions, matching work demands to recovery, discussing costs, planning transport and accommodation, and organizing home help during recovery.
New questions are being added (Fall/Winter 2026).
What active surveillance means, suitability for it, your testing schedule, reassessing PSA rises, how MRI complements repeat biopsies, when higher grade prompts treatment review, managing anxiety, watchful waiting versus active surveillance, when watchful waiting fits, and reporting symptoms during watchful waiting.
New questions are being added (Fall/Winter 2026).
Focal versus whole-prostate treatment, how HIFU destroys tissue with heat, how cryotherapy freezes tissue, electrical pulses that destroy targeted cells, and focal therapy's long-term evidence limits.
New questions are being added (Fall/Winter 2026).
What prostate removal surgery removes, how surgeons control robotic instruments, asking about comparable outcomes, nerve preservation and cancer safety, lymph node removal for staging, anesthesia planning, building fitness before surgery, preoperative medicine instructions, urgent catheter blockage help, postoperative leg swelling, pain relief, wound changes, clot prevention, matching activity to recovery, and information before hospital discharge.
New questions are being added (Fall/Winter 2026).
How radiation is delivered from outside, shaping it to spare tissues, SBRT dose per session, what a radiation fraction means, how imaging and markers guide it, why bladder and bowel preparation matters, rectal spacers that reduce exposure, why external radiation leaves no radioactivity, and how radiation effects can appear later.
New questions are being added (Fall/Winter 2026).
How permanent seeds lose radioactivity, how HDR sources are removed, how urinary symptoms affect suitability, combining internal and external radiation, and precautions after permanent seed treatment.
New questions are being added (Fall/Winter 2026).
Why radiation includes hormone therapy, limits of hormone therapy alone, how risk affects duration, knowing your medicine plan, preventing testosterone flare, lowering testosterone versus blocking signals, abiraterone for selected cancers, why it requires steroids, managing hot flashes, fatigue and sleeplessness, mood and concentration changes, muscle loss, bone density testing, heart and metabolic monitoring, and reporting breast swelling.
New questions are being added (Fall/Winter 2026).
Leakage with coughing or movement, urinary irritation during radiation, pelvic floor contraction and relaxation, getting technique coaching, how pads manage leakage, balanced fluids and bladder irritants, surgery for persistent leakage, assessing a narrowed urine pathway, emergency care for urinary retention, and blood clots blocking urine flow.
New questions are being added (Fall/Winter 2026).
Constipation, dehydration, and bladder symptoms, reporting diarrhea during radiation, why rectal bleeding needs investigation, delayed bowel effects after radiation, and specialist help for bowel problems.
New questions are being added (Fall/Winter 2026).
Why erection recovery varies, erection tablets and nitrate interactions, how vacuum devices work, emergency care for prolonged erections, penile implants, limits of penile rehabilitation, orgasm without ejaculation after surgery, urine leakage during orgasm, penis length changes, and how sexual desire differs from erections.
New questions are being added (Fall/Winter 2026).
Pleasure changes after prostate removal, intimacy without penetration, resuming anal sex safely, sperm banking before treatment, contraception despite reduced fertility, private discussions about sexual concerns, counseling for changed relationships, and discussing treatment effects when dating.
New questions are being added (Fall/Winter 2026).
Changing emotions after diagnosis, seeking help for persistent depression, coping while awaiting test results, body changes and personal identity, peer support versus medical advice, when counseling may help, choosing what to tell others, explaining cancer to children, different coping styles between partners, and protecting the caregiver's health.
New questions are being added (Fall/Winter 2026).
Planning activities around energy levels, gradually adapting exercise during recovery, stamina training versus strength training, dietitian support for eating difficulties, weight goals that protect muscle, benefits of quitting after diagnosis, alcohol and treatment safety, checking supplements with your team, and continuing routine primary care.
New questions are being added (Fall/Winter 2026).
What survivorship care plans include, assigning responsibility for PSA follow-up, expected PSA after prostate removal, slow PSA decline after radiation, recognizing a temporary PSA bounce, how testosterone recovery can affect PSA, PSA trends and rising speed, and what positive surgical margins mean.
New questions are being added (Fall/Winter 2026).
Local versus distant cancer recurrence, how negative scans can miss recurrence, salvage radiation after prostate removal, selecting treatment after radiation recurrence, monitoring selected slow-growing recurrences, back pain with weakness as an emergency, and how spread changes care goals.
New questions are being added (Fall/Winter 2026).
Cancer responsive to hormone treatment, cancer growth despite low testosterone, hormone resistance without detected spread, biopsy for suspected neuroendocrine cancer, what a biopsy reveals, and reviewing unusual cancer tissue findings.
New questions are being added (Fall/Winter 2026).
PSA rise versus confirmed progression, interpreting PSA trends, checking testosterone suppression, combining measures of treatment response, why follow-up schedules differ, progression despite low PSA, cancer progression on imaging, and how different metastases can respond differently.
New questions are being added (Fall/Winter 2026).
What CT scans show, MRI safety with implanted devices, how PSMA PET detects cancer, noncancerous bone scan findings, scans that can miss microscopic cancer, healing-related bone scan flare, and investigating a new lung nodule.
New questions are being added (Fall/Winter 2026).
Recording prior cancer treatments, limits of personal survival predictions, goals of metastatic cancer treatment, local versus whole-body treatments, how previous resistance affects treatment, other illnesses and treatment safety, daily function and treatment tolerance, weighing treatment benefits and harms, the radiation oncologist's role, progression-free versus overall survival, and reassessing cancer control and toxicity.
New questions are being added (Fall/Winter 2026).
Why lowering testosterone helps, how hormone injections lower testosterone, relugolix as oral hormone therapy, permanent testosterone reduction through surgery, hormone injections and testosterone surges, preventing early hormone treatment flare, keeping hormone injections on schedule, continuing ADT despite hormone resistance, supervised breaks from ADT, and variable testosterone recovery after ADT.
New questions are being added (Fall/Winter 2026).
Hot flashes during hormone therapy, fat gain and muscle loss, strength exercise during ADT, blood sugar monitoring during ADT, heart health monitoring during ADT, bone density testing during ADT, anemia during hormone treatment, breast changes during hormone therapy, concerning injection site changes, and hormone tablets, falls, and fractures.
New questions are being added (Fall/Winter 2026).
Urgent action for chemotherapy fever, spinal cord compression warning signs, urgent care for urinary retention, blood clot emergency symptoms, recognizing possible high blood calcium, reporting symptoms between appointments, serious skin reactions to apalutamide, sudden confusion needing urgent assessment, adrenal risks from interrupted steroids, and recognizing bowel obstruction warning signs.
New questions are being added (Fall/Winter 2026).
Draining a blocked kidney, reporting visible blood in urine, assessing leg or genital swelling, keeping urinary catheters draining, TURP to improve urine flow, assessing causes of urine leakage, and urgent assessment of nephrostomy blockage.
New questions are being added (Fall/Winter 2026).
Describing diarrhea or constipation, treatable contributors to fatigue, pacing activities around fatigue, addressing causes of poor sleep, dietitian support for weight loss, adapting meals to taste changes, checking supplements for interactions, complementary care alongside cancer treatment, rehabilitation suited to physical limits, and smoking cessation and alcohol safety.
New questions are being added (Fall/Winter 2026).
Sexual desire versus erections, genital size changes during ADT, medical treatments for erection problems, sildenafil and nitrates being unsafe, orgasm without semen release, and fertility preservation and contraception.
New questions are being added (Fall/Winter 2026).
When to consider clinical trials, phase one trial goals, why trials use random assignment, placebos alongside standard treatment, what a trial protocol specifies, why trial eligibility criteria matter, the purpose of extra trial tests, and uncertain benefits of experimental treatments.
New questions are being added (Fall/Winter 2026).
Cancer keeps its original name, new diagnosis versus metastatic recurrence, local versus distant recurrence, nearby growth versus distant spread, the meaning of M1 staging, cancer grade versus stage, nearby versus distant lymph nodes, common sites of cancer spread, a limited number of metastases, and metastatic cancer without symptoms.
New questions are being added (Fall/Winter 2026).
What blood counts measure, kidney and liver safety checks, keeping a complete medicine list, food instructions for cancer tablets, prescribed treatment pauses for recovery, dose reductions for side effects, safety monitoring for cancer tablets, safety checks after changing treatment, liver function and medicine dosing, reviewing medicines for drug interactions, and safe storage of relugolix.
New questions are being added (Fall/Winter 2026).
Blocking testosterone production or signaling, why abiraterone needs a steroid, different hormone tablets and different risks, adding hormone tablets to ADT, starting chemotherapy alongside ADT, components of triple therapy, seizure history before enzalutamide, abiraterone safety monitoring, and steroids and raised blood sugar.
New questions are being added (Fall/Winter 2026).
Goals of chemotherapy, cabazitaxel after docetaxel, ports for intravenous chemotherapy, recovery time between chemotherapy cycles, factors determining chemotherapy duration, steroids before docetaxel, hair loss versus treatment response, infection precautions with low neutrophils, medicines supporting white cell recovery, recognizing symptoms of anemia, platelets and bleeding risk, preventing chemotherapy nausea, mouth sores affecting drinking, and reporting chemotherapy nerve symptoms.
New questions are being added (Fall/Winter 2026).
Tumor testing for treatment options, inherited versus tumor-only gene changes, BRCA results and targeted treatment, family history for genetic counseling, how PARP inhibitors work, eligibility for PARP inhibitor regimens, blood counts during PARP treatment, different immunotherapies and different eligibility, PTEN testing for targeted treatment, and sipuleucel-T using your immune cells.
New questions are being added (Fall/Winter 2026).
Who may receive radium-223, how PSMA-targeted radiation works, PSMA scans versus PSMA treatment, radioactive medicines versus external radiation, blood tests during radioactive treatment, following home radiation precautions, dry mouth after PSMA treatment, and urine precautions after PSMA treatment.
New questions are being added (Fall/Winter 2026).
Radiation for pelvic tumor bleeding, safety of repeat radiation, prostate radiation for limited spread, limits of treating visible metastases, radiation for painful bone metastases, planning and positioning for radiation, urinary irritation during radiation, reporting bowel changes during radiation, and pain flare after bone radiation.
New questions are being added (Fall/Winter 2026).
Bone metastases versus bone thinning, medicines reducing bone complications, dental checks before bone medicines, kidney checks with zoledronic acid, personalized calcium and vitamin D, and exercise safety with bone metastases.
New questions are being added (Fall/Winter 2026).
Recording pain patterns and impact, choosing an individualized pain plan, recognizing breakthrough pain, preventing opioid constipation, opioid drowsiness and driving safety, palliative care alongside cancer treatment, opioid alternatives for swallowing difficulties, assessing oxygen levels and breathlessness, hospice providing active symptom relief, and draining fluid around the lung.
New questions are being added (Fall/Winter 2026).